AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (AGIO)

Q: What does CUSIP 00847X104 represent in this 13F holders report?

CUSIP 00847X104 is the security identifier for AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share in Q3 2025?

216 institutional investors reported AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share for Q3 2025. Use the holders table for investor-level position and value details.

CUSIP: 00847X104

Q3 2025 13F Holders as of 30 Sep 2025

Security type / class: Equity / Common Stock, Par Value $0.001 per share
Total 13F shares: 63,487,439
Total 13F value: $2,545,616,686
Share change: +1,630,522
Put/Call ratio: 91%
SEC-reported price per share: $40.14
Number of holders: 216
Value change: +$81,769,351
Number of buys: 105
Number of sells: 103
Shares outstanding: 59,490,804

Security key

00847X104

Report period

Q3 2025

Institutions

216

Top holders

AGIO full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2026 AGIOS PHARMACEUTICALS, INC. SEC filings AGIOS PHARMACEUTICALS, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 00847X104

Newer quarter: Q2 2026

Recent filing periods:

Q2 2026

Ownership snapshot

Top reported holders of AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

BlackRock, Inc.

Disclosed value leader

FARALLON CAPITAL MANAGEME...

Comparable rows

15/15

Latest evidence

30 Sep 2025

13F 13D/G Lead comparable stake: 7.8% 13D/G row: BlackRock, Inc. Showing 1-6 of 15 holder rows.

Quick read

BlackRock, Inc. leads the comparable SEC ownership view at 7.8%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock, Inc.'s linked filing trail.

Comparable ownership Top 5

BlackRock, Inc. 7.8%

Paradigm Biocapital Advisors LP 4.9%

FARALLON CAPITAL MANAGEMENT, L.L.C. 9.7%

VANGUARD GROUP INC 9.6%

Bellevue Group AG 6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
BlackRock, Inc.	13F 13D/G Company 13F 13D/G	7.8% from 13D/G	$160,770,870 4,833,760 shares	—	30 Jun 2025
Paradigm Biocapital Advisors LP	13D/G 13F Company 13D/G 13F	4.9%	$115,344,498 2,873,555 shares	-$6,198,499	30 Sep 2025
FARALLON CAPITAL MANAGEMENT, L.L.C.	13F Company 13F	9.7%	$191,825,919 5,767,466 shares	—	30 Jun 2025
VANGUARD GROUP INC	13F Company 13F	9.6%	$188,983,952 5,682,019 shares	—	30 Jun 2025
Bellevue Group AG	13F Company 13F	6%	$119,408,389 3,590,150 shares	—	30 Jun 2025
Erste Asset Management GmbH	13F Company 13F	3.9%	$77,401,053 2,326,489 shares	—	30 Jun 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

216

63,487,439

Rows available

216

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders

211

Q3 2025 holders

216

Holder diff

Investor	Q2 2025 Shares	Q3 2025 Shares	Share Diff	Share Chg %	Q2 2025 value	Q3 2025 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend